Districts providing antiretroviral combination therapy
This indicator is important to measure the coverage of antiretroviral combination therapy within a country by looking at the number of districts in which this treatment is available.
Number of districts with at least one health facility providing antiretroviral combination therapy
Total number of districts
The numerator will include different types of nongovernmental organization or government health facilities (such as social security or military), depending on the level of involvement of these sectors in providing antiretroviral combination therapy.
The following methods are recommended:
Record reviews of the district medical office or district AIDS office, which may have a list of all facilities providing antiretroviral combination therapy
Record reviews of the national AIDS programme or a national drug management system of the ministry of health that should also have a listing of the facilities at which antiretroviral combination therapy is available
Health facility survey
Having data on district population and the prevalence per district is useful to compare how the availability of services matches the needs.
Geographic location: N/A
Pregnancy status: N/A
Time period: N/A
Type of orphan: N/A
Vulnerability status: N/A
The method of measuring this indicator depends strongly on the ability of the national and/or district levels to collect and provide this information. This indicator is especially useful in countries where antiretroviral combination therapy is first being initiated and/or in places in which antiretroviral combination therapy is only available in a few districts. As more districts begin to provide antiretroviral combination therapy, countries should move to measuring the total coverage the number of people who are receiving antiretroviral combination therapy divided by the total number of people in need (see care and support core indicator 3, Antiretroviral combination therapy). To be useful, this indicator therefore needs to be adapted as services become widely available. If a health facility survey is used, facilities that provide antiretroviral combination therapy must be intentionally sampled.